Enable Block: 

GENEVA: The World Health Organization has a message for those trying to understand how the latest Ebola outbreak was contained so quickly: don't give the new vaccine all the credit.

Researchers have found that protein found in human semen significantly increases Ebola virus infection, explaining how sexual transmission has led to the virus' resurgence.

The global epidemiological trends of many viral diseases clearly indicate resurgence of some hitherto quiescent yet virulent pathogens and emergence of new strains that pose a challenge to medical

In a double move hailed as a milestone for public health, African leaders have launched an agency to tackle global threats such as Ebola and pledged to make immunisation available throughout the co

The ongoing West African Ebola epidemic began in December 2013 in Guinea, probably from a single zoonotic introduction. As a result of ineffective initial control efforts, an Ebola outbreak of unprecedented scale emerged. As of 4 May 2015, it had resulted in more than 19,000 probable and confirmed Ebola cases, mainly in Guinea (3,529), Liberia (5,343), and Sierra Leone (10,746). Here, we present analyses of data collected during the outbreak identifying drivers of transmission and highlighting areas where control could be improved.

Evidence for minimally symptomatic Ebola virus (EBOV) infection is limited. During the 2013–16 outbreak in West Africa, it was not considered epidemiologically relevant to published models or projections of intervention effects. In order to improve our understanding of the transmission dynamics of EBOV in humans, we investigated the occurrence of minimally symptomatic EBOV infection in quarantined contacts of reported Ebola virus disease cases in a recognized ‘hotspot.’

The UN General Assembly will meet on September 13.

The first Phase-1 human clinical trial of a vaccine for the Zika virus is set to begin in the coming weeks, with the U.S. Food and Drug Administration (FDA) green-lighting it.

We assess how presymptomatic infection affects predictability of infectious disease epidemics. We focus on whether or not a major outbreak (i.e. an epidemic that will go on to infect a large number of individuals) can be predicted reliably soon after initial cases of disease have appeared within a population. For emerging epidemics, significant time and effort is spent recording symptomatic cases. Scientific attention has often focused on improving statistical methodologies to estimate disease transmission parameters from these data.

Scientists have warned that humans should brace for the emergence of a new virus that could be deadlier than Ebola Virus Disease (EVD), Severe Acute Respiratory Syndrome (SARS) or Zika.